{"nct_id":"NCT03338790","title":"An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2017-12-19","start_date_type":"ACTUAL","primary_completion_date":"2021-01-13","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}